05Jul 2022
Arginine Therapy and Cardiopulmonary Hemodynamics in Hospitalized Children with Sickle Cell Anemia: A Prospective, Double-blinded, Randomized Placebo-controlled Clinical Trial

Arginine Therapy and Cardiopulmonary Hemodynamics in Hospitalized Children with Sickle Cell Anemia: A Prospective, Double-blinded, Randomized Placebo-controlled Clinical Trial

To evaluate the effects of l-arginine supplementation on Doppler indices of cardiopulmonary hemodynamics in children with sickle cell anaemia experiencing pain. A greater reduction in median TRV occurred in the arginine group than placebo. In addition, a larger percentage increase in global arginine bioavailability was associated with a lower TRV after 5 days of supplementation. Oral arginine supplementation improves cardiopulmonary hemodynamics during sickle cell disease, vasoocclusive pain and ACS.

  • #critical care

Like

Save

Share